HemaCare Corp. (HEMA.OB) Reports Increase in Second Quarter Profit with Record Revenue
HemaCare Corporation, a rising young company that provides blood products and services in the healthcare industry, announced today second quarter 2009 results which include a 5% increase in revenue compared to the same quarter in 2008. HemaCare, which is licensed by the FDA and accredited by the AABB, showed income from continuing operations of $369,000 for the second quarter which dwarfed the $165,000 for the same quarter in 2008. This represents an increase of 124% or $0.04 per share. When asked about the impact of these numbers, HemaCare CEO John Doumitt responded, "We are pleased to report record revenues and…